Type I IFN innate immune response to adenovirus-mediated IFN-gamma gene transfer contributes to the regression of cutaneous lymphomas
about
Key role of splenic myeloid DCs in the IFN-alphabeta response to adenoviruses in vivoInfluenza a virus induces an immediate cytotoxic activity in all major subsets of peripheral blood mononuclear cells.Systemic treatment of xenografts with vaccinia virus GLV-1h68 reveals the immunologic facet of oncolytic therapy.Phase II clinical trial of intratumoral application of TG1042 (adenovirus-interferon-gamma) in patients with advanced cutaneous T-cell lymphomas and multilesional cutaneous B-cell lymphomas.TG1042 (Adenovirus-interferon-γ) in primary cutaneous B-cell lymphomas: a phase II clinical trialIn vivo profiling reveals immunomodulatory effects of sorafenib and dacarbazine on melanoma.Pharmacologic activation of the innate immune system to prevent respiratory viral infections.The immunologic aspects of poxvirus oncolytic therapyRefractoriness of interferon-beta signaling through NOD1 pathway in mouse respiratory epithelial cells using the anticancer xanthone compoundAn infection-enhanced oncolytic adenovirus secreting H. pylori neutrophil-activating protein with therapeutic effects on neuroendocrine tumors.New targets of therapy in T-cell lymphomas.Management of cutaneous T cell lymphoma: new and emerging targets and treatment options.Immune recognition of gene transfer vectors: focus on adenovirus as a paradigm.Immunological milieu in mycosis fungoides and Sézary syndrome.Adenovirus-triggered innate signalling pathways.beta(2)microglobulin mRNA expression levels are prognostic for lymph node metastasis in colorectal cancer patients.A practical guide to the handling and administration of talimogene laherparepvec in Europe.Ad.Egr-TNF and local ionizing radiation suppress metastases by interferon-beta-dependent activation of antigen-specific CD8+ T cellsVersican upregulation in Sézary cells alters growth, motility and resistance to chemotherapy.New Therapies and Immunological Findings in Cutaneous T-Cell Lymphoma.
P2860
Q27318346-486D5A0E-8132-4BCD-B1B1-08251B6D30D0Q33397737-6EAE9859-81C8-44B3-B11A-49AF82A3AD53Q33479314-93C10398-D161-4275-B226-B62A60340908Q33930161-B32F574E-894B-497A-BC26-F2213D2B568BQ35105819-4E75829C-9044-448F-A30E-A7B251730118Q35506764-38038022-78A1-46D3-8F8D-D4E7B4608669Q35692082-77ED355A-68E9-4FA5-BA4D-C30F699ABE34Q36115128-94CB5DD7-9B7D-4F87-8239-2BDE3634CAFCQ36839796-72A58060-0D25-4CBC-9BF2-77BC0EE19D3BQ37316842-F5188174-F1CD-446F-AC67-75A7E737BB8CQ37701472-5A878B00-B1BA-4137-AE64-D7CC4D30C6FBQ37998019-ACE08BC4-84B2-407A-93EF-F7E0C04CAB81Q38008337-0A7B03B0-8BCB-49EC-BBE8-A4ECA0E67FF9Q38179489-AAA53E8C-0354-4F3F-B0BA-397AC2893780Q38187126-3C24627C-F8BA-4CA7-B873-F0CB80AB4AFCQ39637991-95781726-566D-4FB2-88C6-7E906F7CE6A9Q40080717-BC794F81-D115-4E55-AE26-81581A8DDEF7Q41309983-FC41C250-4A89-4FD6-AAE0-F883D7383184Q53528268-439CC65C-E270-40CC-A2C5-9097C7A32E15Q55334211-FA484C4E-AE96-4382-97A9-B6404E5B20DD
P2860
Type I IFN innate immune response to adenovirus-mediated IFN-gamma gene transfer contributes to the regression of cutaneous lymphomas
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Type I IFN innate immune respo ...... ression of cutaneous lymphomas
@en
Type I IFN innate immune respo ...... ression of cutaneous lymphomas
@nl
type
label
Type I IFN innate immune respo ...... ression of cutaneous lymphomas
@en
Type I IFN innate immune respo ...... ression of cutaneous lymphomas
@nl
prefLabel
Type I IFN innate immune respo ...... ression of cutaneous lymphomas
@en
Type I IFN innate immune respo ...... ression of cutaneous lymphomas
@nl
P2093
P2860
P356
P1476
Type I IFN innate immune respo ...... ression of cutaneous lymphomas
@en
P2093
Bastien Calmels
Bruce Acres
Elisabeth Laine
Kazuyasu Fujii
Mirjana Urosevic
Nikita Kobert
Reinhard Dummer
P2860
P304
P356
10.1172/JCI32077
P407
P577
2007-10-01T00:00:00Z